BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23632812)

  • 1. Overexpression of retinoic acid-induced protein 3 predicts poor prognosis for hepatocellular carcinoma.
    Zheng J; Guo X; Gao X; Liu H; Tu Y; Zhang Y
    Clin Transl Oncol; 2014 Jan; 16(1):57-63. PubMed ID: 23632812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.
    Liu F; Zhang Y; Peng Z; Gao H; Xu L; Chen M
    J Transl Med; 2012 Jul; 10():135. PubMed ID: 22747650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
    Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
    Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
    Chen XQ; He JR; Wang HY
    Med Oncol; 2012 Sep; 29(3):1843-9. PubMed ID: 21987076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
    Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
    World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of sineoculis homeobox homolog 1 predicts poor prognosis of hepatocellular carcinoma.
    Kong J; Zhou X; Liu S; Jin T; Piao Y; Liu C; Lin Z
    Int J Clin Exp Pathol; 2014; 7(6):3018-27. PubMed ID: 25031720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.
    Guo X; Xiong L; Sun T; Peng R; Zou L; Zhu H; Zhang J; Li H; Zhao J
    Diagn Pathol; 2012 Apr; 7():44. PubMed ID: 22515642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis.
    Qiu X; Zheng J; Guo X; Gao X; Liu H; Tu Y; Zhang Y
    Mol Cell Biochem; 2013 Jun; 378(1-2):99-106. PubMed ID: 23475171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.
    Li J; Zhu YH; Huang P; Zhang B; Sun J; Guan XY
    Diagn Pathol; 2015 Aug; 10():136. PubMed ID: 26249031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of AP-4 predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.
    Hu BS; Zhao G; Yu HF; Chen K; Dong JH; Tan JW
    Tumour Biol; 2013 Feb; 34(1):271-6. PubMed ID: 23055200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of myofibrillogenesis regulator-1 predicts poor prognosis for patients with hepatocellular carcinoma after curative hepatectomy.
    Wang C; Xiang H; Si H; Guo D; Sun M
    Int J Clin Exp Pathol; 2015; 8(11):14818-23. PubMed ID: 26823810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Leucine Zipper Protein mRNA in Hepatocellular Carcinoma Associated With Poor Prognosis.
    Li G; Yuan L; Liu D; Liu J
    Technol Cancer Res Treat; 2016 Jun; 15(3):517-22. PubMed ID: 26031464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients.
    Ding Y; Chen B; Wang S; Zhao L; Chen J; Ding Y; Chen L; Luo R
    Int J Cancer; 2009 Feb; 124(3):653-8. PubMed ID: 18972435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NORE1A sensitises cancer cells to sorafenib-induced apoptosis and indicates hepatocellular carcinoma prognosis.
    Liu LL; Zhang MF; Pan YH; Yun JP; Zhang CZ
    Tumour Biol; 2014 Mar; 35(3):1763-74. PubMed ID: 24563371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of TRIM3 is associated with poor prognosis in patients with primary hepatocellular carcinoma.
    Chao J; Zhang XF; Pan QZ; Zhao JJ; Jiang SS; Wang Y; Zhang JH; Xia JC
    Med Oncol; 2014 Aug; 31(8):102. PubMed ID: 24994609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
    Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
    Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.